Erythromycin Delayed-Release Capsules

This is a preview of
USP-NF/PF content.

Subscriber?
Access here! Not a subscriber?
Learn more!

» Erythromycin Delayed-Release Capsules contain not less than 90.0 percent and not more than 115.0 percent of the labeled amount of erythromycin (C₃₇H₆₇NO₁₃).

USP REFERENCE STANDARDS FOR PURCHASE

USP Erythromycin RS

This is a preview of
USP-NF/PF content.

Subscriber?
Access here!Not a subscriber?
Learn more!